Try our Advanced Search for more refined results

Acorda Blasts Bass-Backed Group's Bid To Nix Drug Patents

By Kevin Penton (December 15, 2015, 9:36 PM EST) -- Acorda Therapeutics Inc. fought back Monday against a bid by a group with close ties to hedge fund manager Kyle Bass to invalidate four of its patents related to its multiple sclerosis drug Ampyra through America Invents Act reviews, arguing that one of the prior art cited does not qualify as a printed publication....

Law360 is on it, so you are, too.

A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.


A Law360 subscription includes features such as

  • Daily newsletters
  • Expert analysis
  • Mobile app
  • Advanced search
  • Judge information
  • Real-time alerts
  • 450K+ searchable archived articles

And more!

Experience Law360 today with a free 7-day trial.

Start Free Trial

Already a subscriber? Click here to login

Attached Documents

Related Sections

PTAB Case Information

Case Title

Subscribers Only

Case Number

Subscribers Only

Date Filed

Subscribers Only

Law Firms

Companies

Government Agencies

Patents

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!